NatWest Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-31,280
| Closed | -$480K | – | 395 |
|
|
2015
Q3 | $480K | Buy |
31,280
+477
| +2% | +$7.32K | 0.01% | 284 |
|
|
2015
Q2 | $749K | Sell |
30,803
-477
| -2% | -$11.6K | 0.01% | 212 |
|
|
2015
Q1 | $727K | Sell |
31,280
-7,263
| -19% | -$169K | 0.01% | 268 |
|
|
2014
Q4 | $968 | Buy |
38,543
+3,485
| +10% | +$88 | 0.01% | 218 |
|
|
2014
Q3 | $1.09K | Buy |
35,058
+12,915
| +58% | +$402 | 0.01% | 247 |
|
|
2014
Q2 | $573K | Buy |
22,143
+4,810
| +28% | +$124K | 0.02% | 335 |
|
|
2014
Q1 | $405K | Sell |
17,333
-376
| -2% | -$8.79K | 0.02% | 363 |
|
|
2013
Q4 | $449K | Buy |
17,709
+3,788
| +27% | +$96K | 0.01% | 589 |
|
|
2013
Q3 | $284K | Buy |
13,921
+784
| +6% | +$16K | 0.01% | 905 |
|
|
2013
Q2 | $276K | Buy |
+13,137
| New | +$276K | ﹤0.01% | 682 |
|